India Pharma Outlook Team | Monday, 12 October 2026
A quiet global health reset gathers force as nations confront mental health shortfalls, pioneer extreme-environment research, and confront the rising tide of non-communicable diseases.
Nearly 48 lakh calls to Tele-MANAS over four years prove that demand for mental health support has surged, and India meets that demand with free, round-the-clock digital care.
At the same time, the World Health Organization warns that 81 percent of countries still deliver mental health services inside psychiatric hospitals.
In the remote Himalayan town of Keylong, Union Health Minister J P Nadda lays the foundation stone of India’s first ICMR Centre for High-Altitude Medicine. This aims to convert the challenges of climate, terrain and isolation into a research advantage.
Roche, meanwhile, presses for a complete overhaul of healthcare systems to blunt a USD 5-trillion chronic-disease wave. Similarly, points out that emerging economies such as India can leapfrog the outdated 1950s hospital model that still constrains much of the West.
India has turned to Tele-MANAS, its national mental health helpline, as people seek help for everyday pressures. The service has received 47,75,644 calls since its launch on 10 October 2022.
Of the 13.35 lakh caller profiles analyzed by the Union Health Ministry, 73.2 percent belonged to people aged 18-45. Men made up 54.18 percent of those profiles and women 43.78 percent.
Callers most often raise concerns about exam stress, workplace pressure, anxiety, sleep problems, and relationship difficulties. The free and confidential service operates 24 hours a day on the number 14416 through 53 operational cells that cover all 36 States and Union Territories.
The government has sanctioned the District Mental Health Program in 767 districts and has integrated mental health services into more than 1.83 lakh Ayushman Arogya Mandirs.
A new WHO guide released ahead of World Mental Health Day shows how far the rest of the world still lags:
WHO urges countries to deliver care closer to people’s homes and to back that care with community services, rehabilitation, housing and ongoing clinical support. It cautions that simply closing hospitals without proper follow-up risks leaving people without care.
Also Read: How Can Indian Pharma Strengthen Quality Amid Rising FDA Scrutiny
Union Health Minister J P Nadda lays the foundation stone of the ICMR Center for High Altitude Medicine and Public Health Research in Keylong, Lahaul and Spiti district of Himachal Pradesh.
The center becomes India’s first dedicated facility for high-altitude medicine and public health research. It focuses on the public-health challenges that arise from high altitude, extreme weather, difficult terrain, geographical isolation, and climate variability.
Researchers at the center will examine:
The center will also test digital health platforms, telemedicine, drone-enabled logistics and real-time public health surveillance so that healthcare can reach remote and hard-to-access communities.
Long-term field studies will track how environmental conditions and climate variability shape health outcomes. The work will advance tribal health, disaster preparedness and climate-resilient healthcare systems.
Collaboration with the Armed Forces Medical Services, national research institutions and the Himachal Pradesh government will drive translational research, capacity building and evidence-based policy. The center will strengthen India’s contribution to global research in high-altitude medicine.
Roche has called for a structural overhaul of global healthcare systems to tackle the explosive rise of non-communicable diseases such as cancer, diabetes, heart conditions and Alzheimer’s.
Jorg Rupp, who leads Roche’s international operations across more than 100 countries, told media representatives that today’s systems remain trapped in the mid-20th century and now face a profound structural crisis.
Rupp explained that those systems were built to treat sudden, acute illnesses. Diseases today are complex, multi-year, and chronic. The burden of illness has shifted permanently, yet delivery systems, financing models, and administrative mindsets remain locked in the 1950s.
Over the next decade, the direct and indirect costs of treating chronic diseases will exceed USD 5 trillion. Poor health and untreated chronic disease already generate global productivity losses of up to 15 percent of GDP each year.
Nearly 13,000 new medicines are in clinical development worldwide, and 75 percent of those pipeline assets target non-communicable diseases. Roche itself invests USD 14 billion every year in research.
These advances allow clinicians to identify disease earlier, design medicines faster and tailor therapies to individual patients. Rupp urged governments to treat healthcare as an investment rather than a short-term cost.
Together, these developments scaled digital mental health support, high-altitude research leadership, and the clear call for NCD system redesign. This shows how proactive and accessible care can advance even while many health systems remain anchored to outdated hospital-centric models.
.jpg)
